Published in Gene Therapy Weekly, February 11th, 2010
"Cell viabililty was measured by MTT assay. Apoptosis was detected by flow cytometry assay. Notch-1, Hes-1, caspase-3 p20 and NF-kappa B p65 expressions were assayed by Western blotting. NF-kappa B activation was tested by electrophoretic mobility shift assay (EMSA), and caspase-3 activation was tested by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2010-02-11)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.